Regular dose of gemcitabine induces an increase in CD14+ monocytes and CD11c+ dendritic cells in patients with advanced pancreatic cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/19797418

Download in:

View as

General Info

PMID
19797418